Personalis (PSNL) News Today $5.93 +0.08 (+1.37%) Closing price 04:00 PM EasternExtended Trading$5.94 +0.00 (+0.08%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PSNL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 15 at 5:35 PM | businesswire.comPersonalis (NASDAQ:PSNL) Trading Down 4.1% - Here's WhySeptember 14 at 11:47 AM | marketbeat.comPersonalis (NASDAQ:PSNL) Shares Down 4.1% - Time to Sell?September 14 at 3:55 AM | americanbankingnews.comPersonalis (NASDAQ:PSNL) Stock Price Up 6.5% - What's Next?September 13 at 12:59 PM | marketbeat.comPersonalis' MRD Breakthrough Potential: Why I Hold Until Reimbursement Clarity EmergesSeptember 11, 2025 | seekingalpha.comPersonalis collaborates with Yale Cancer Center over CATE clinical trialSeptember 10, 2025 | msn.comCATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal TestSeptember 10, 2025 | businesswire.comPersonalis' (PSNL) "Buy" Rating Reaffirmed at HC WainwrightSeptember 10, 2025 | marketbeat.comHead to Head Review: Personalis (NASDAQ:PSNL) versus Targeted Medical Pharma (OTCMKTS:TRGM)September 10, 2025 | americanbankingnews.comPersonalis, Inc. $PSNL Stake Boosted by Trexquant Investment LPSeptember 10, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Earns Buy Rating from HC WainwrightSeptember 10, 2025 | americanbankingnews.comPersonalis reports data from AstraZeneca phase 3 clinical trial in lung cancerSeptember 4, 2025 | msn.comPersonalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD TestingSeptember 3, 2025 | finance.yahoo.comPersonalis Earnings Call: Growth Amidst Financial ChallengesAugust 29, 2025 | theglobeandmail.comPersonalis to Participate in Upcoming Investor ConferencesAugust 27, 2025 | businesswire.comPersonalis, Inc. (NASDAQ:PSNL) Receives Consensus Rating of "Buy" from BrokeragesAugust 25, 2025 | marketbeat.comAberdeen Group plc Purchases 1,406,895 Shares of Personalis, Inc. $PSNLAugust 23, 2025 | marketbeat.comPersonalis gains as VA awards work order worth up to $13.5MAugust 22, 2025 | msn.comPersonalis Secures New VA Contract Task OrderAugust 22, 2025 | tipranks.comCathie Wood’s ARK Investment buys 133.3K shares of Personalis todayAugust 15, 2025 | msn.comPersonalis (NASDAQ:PSNL) Rating Lowered to Sell at Wall Street ZenAugust 10, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Personalis Q3 Earnings?August 9, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportAugust 8, 2025 | finance.yahoo.comPSNL | Personalis Inc. Annual Income Statement | MarketWatchAugust 7, 2025 | marketwatch.comPersonalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comPersonalis (NASDAQ:PSNL) Given New $8.50 Price Target at HC WainwrightAugust 7, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Posts Earnings Results, Beats Expectations By $0.02 EPSAugust 6, 2025 | marketbeat.comPersonalis (PSNL) Q2 Revenue Falls 24%August 6, 2025 | fool.comPersonalis, Inc. (PSNL) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comPersonalis reports Q2 EPS (23c), consensus (24c)August 5, 2025 | msn.comPersonalis Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | finance.yahoo.comPersonalis Q2 2025 Earnings PreviewAugust 5, 2025 | msn.comPersonalis (NASDAQ:PSNL) Shares Down 7.4% - What's Next?July 30, 2025 | marketbeat.comPersonalis (PSNL) Projected to Post Earnings on TuesdayJuly 30, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Receives Consensus Rating of "Buy" from AnalystsJuly 29, 2025 | marketbeat.comARK Investment Management LLC Has $25.23 Million Stake in Personalis, Inc. (NASDAQ:PSNL)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Sells 57,339 Shares of Personalis, Inc. (NASDAQ:PSNL)July 27, 2025 | marketbeat.comPersonalis to Announce Second Quarter 2025 Financial ResultsJuly 22, 2025 | businesswire.comPersonalis, Inc. (NASDAQ:PSNL) Stake Lifted by AIGH Capital Management LLCJuly 22, 2025 | marketbeat.comPersonalis, Inc. (PSNL) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comPersonalis and Tempus extend cancer detection collaboration to 2029July 11, 2025 | investing.comPersonalis Expands Tempus Strategic Collaboration to Bring Ultra ...July 11, 2025 | morningstar.comMPersonalis (NASDAQ:PSNL) Shares Down 6.1% - Time to Sell?July 10, 2025 | marketbeat.comPersonalis, Tempus Expand Detection Test to Include Colorectal CancerJuly 9, 2025 | marketwatch.comStocks to Watch: Nurix Therapeutics, Personalis, WK KelloggJuly 9, 2025 | marketwatch.comPersonalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer PatientsJuly 9, 2025 | finance.yahoo.comPersonalis, Inc. (NASDAQ:PSNL) Stake Lessened by Sumitomo Mitsui Trust Group Inc.July 5, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Buy" by BrokeragesJuly 4, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Trading Down 3.5% - Here's WhyJuly 3, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Hits New 12-Month High - Here's WhyJuly 2, 2025 | marketbeat.com Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PSNL Media Mentions By Week PSNL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSNL News Sentiment▼0.380.94▲Average Medical News Sentiment PSNL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSNL Articles This Week▼113▲PSNL Articles Average Week Get the Latest News and Ratings for PSNL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Personalis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NHC News Today AVAH News Today PACS News Today NAKA News Today VRDN News Today OMDA News Today TDOC News Today GRAL News Today AHCO News Today FTRE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSNL) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSNL Stock Alerts